Renaissance BioScience Corp., a global leader in yeast bioengineering, announced the appointment of Dr. James Tansey to its Board of Directors. Dr. Tansey brings a wealth of experience as a serial entrepreneur, research academic, and business leader, with a focus on life sciences, technology commercialization, and corporate governance. He is a professor at the University of British Columbia's Sauder School of Business and previously served on the faculty at Oxford University's Saïd Business School.
Dr. Tansey is a member of the founding team at Gemina Labs, where he supports fundraising, business development, and shareholder strategy. He also serves on the boards of dynaCERT Inc. and Vanadium Resources Ltd., and is a Senior Advisor to InBC, British Columbia's $500 million strategic investment fund. His appointment is expected to bolster Renaissance's strategic direction as the company continues to develop and commercialize its technology platforms, which include yeast-produced RNA and yeast-derived virus-like particles (VLPs) for applications in crop protection, animal health, and human health.
“We are delighted to welcome Dr. Tansey to the Renaissance Board of Directors,” said Maurice Boucher, Renaissance Co-Founder and Executive Chairman. “James brings an outstanding combination of entrepreneurial, strategic and governance experience, together with a strong track record of helping innovative technology companies grow.” Boucher added, “James has consistently focused on 'Impact Investing' and environmental protection and sustainability throughout his exceptional career, which fits well with the positive environmental impact of Renaissance's technology platforms. His expertise will be a valuable asset for Renaissance as we continue developing and globally commercializing our biotechnology platforms.”
Dr. Tansey commented: “Renaissance has developed an impressive portfolio of innovative technologies with significant commercial potential across agriculture, industrial biotechnology and animal and human health. I look forward to working with the Board and management team to help the company execute on its growth strategy and create long-term value.”
Dr. John Husnik, Renaissance Co-Founder, Director and CSO, commented: “We are excited to welcome Dr. Tansey to our board. His experience building companies, securing investment, and helping innovative technologies move toward commercialization will complement our scientific expertise and support Renaissance as we continue developing and expanding our leading technology platforms.”
This appointment underscores Renaissance's commitment to strengthening its leadership team as it advances its yeast bioengineering platforms. The company's innovative technologies aim to address environmental and industrial challenges in agriculture, food, nutrition, and health, with a focus on sustainability and impact. More information about Renaissance BioScience Corp. can be found at www.renaissancebioscience.com.
